Shidlovski Baird said it thinks recent weakness in Ocular Therapeutix (NASDAQ:OCUL) shares is “overdone” and remains bullish on the company’s…
Read More »Baird
peterschreiber.media Baird has initiated coverage of Nuvalent (NASDAQ:NUVL) with an outperform rating, citing the potential of its two lead assets,…
Read More »sutthirat sutthisumdang Baird has chosen Alcon (NYSE:ALC), Stryker (NYSE:SYK), The Cooper Companies (NASDAQ:COO), Axonics (NASDAQ:AXNX) and Boston Scientific (NYSE:BSX) as…
Read More »